These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 4674146)

  • 1. [Symposium on autoimmune diseases. 7. Experimental study on the development of autoimmune disease in New Zealand mice (NZB-WF 1 hybrid)].
    Shiokawa Y; Abe C; Inaga S; Okada T
    Nihon Naika Gakkai Zasshi; 1972 Jun; 61(6):613-7. PubMed ID: 4674146
    [No Abstract]   [Full Text] [Related]  

  • 2. Male New Zealand Black/KN mice: a novel model for autoimmune-induced permanent alopecia?
    Hiroi A; Ito T; Seo N; Uede K; Yoshimasu T; Ito M; Nakamura K; Ito N; Paus R; Furukawa F
    Br J Dermatol; 2006 Aug; 155(2):437-45. PubMed ID: 16882186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of H-2 heterozygosity for autoimmunity in (NZB X NZW)F1 hybrid mice.
    Hirose S; Ueda G; Noguchi K; Okada T; Sekigawa I; Sato H; Shirai T
    Eur J Immunol; 1986 Dec; 16(12):1631-3. PubMed ID: 2949983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice.
    McCoy KL; Kendrick L; Chused TM
    J Immunol; 1986 Feb; 136(4):1217-22. PubMed ID: 3944456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune diseases and immunological abnormalities seen in New Zealand mice and SLE in man].
    Shirai S; Koika T
    Ryumachi; 1977 Oct; 17(5):516-25. PubMed ID: 304250
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunological function and diseases; a study using New Zealand mice].
    Shiokawa Y; Abe T
    Nihon Rinsho; 1973 Dec; 31(12):3355-61. PubMed ID: 4799678
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunologic abnormality in NZB/NZW F1 mice. Thymus-independent occurrence of B cell abnormality and requirement for T cells in the development of autoimmune disease, as evidenced by an analysis of the athymic nude individuals.
    Mihara M; Ohsugi Y; Saito K; Miyai T; Togashi M; Ono S; Murakami S; Dobashi K; Hirayama F; Hamaoka T
    J Immunol; 1988 Jul; 141(1):85-90. PubMed ID: 3259971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of congenital immunologic mutants to probe autoimmune disease in New Zealand mice.
    Waegell WO; Gershwin ME; Castles JJ
    Prog Clin Biol Res; 1987; 229():175-97. PubMed ID: 2955425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of a gene for the increased susceptibility of B1 cells to Mott cell formation in murine autoimmune disease.
    Jiang Y; Hirose S; Hamano Y; Kodera S; Tsurui H; Abe M; Terashima K; Ishikawa S; Shirai T
    J Immunol; 1997 Jan; 158(2):992-7. PubMed ID: 8993021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of autoimmune disease in NZB and NZB-NZW F1 hybrid mice by infection with malaria.
    Greenwood BM; Voller A
    Trans R Soc Trop Med Hyg; 1970; 64(1):7. PubMed ID: 5309735
    [No Abstract]   [Full Text] [Related]  

  • 11. Isoprinosine delays the early appearance of autoimmunity in NZB/NZW F1 mice treated with interferon.
    Sergiescu D; Cerutti I; Kahan A; Piatier D; Efthymiou E
    Clin Exp Immunol; 1981 Jan; 43(1):36-45. PubMed ID: 6166417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in expression of lupus nephritis in New Zealand mixed H-2z homozygous inbred strains of mice derived from New Zealand black and New Zealand white mice. Origins and initial characterization.
    Rudofsky UH; Evans BD; Balaban SL; Mottironi VD; Gabrielsen AE
    Lab Invest; 1993 Apr; 68(4):419-26. PubMed ID: 8479150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine models of autoimmune disease.
    Mountz JD; Edwards CK
    Curr Opin Rheumatol; 1992 Oct; 4(5):621-9. PubMed ID: 1419496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of cytotoxic autoantibody to lacrimal gland cells in NZB/W mice.
    Ohashi Y; So SK; Minasi PN; Tabbara KF
    Invest Ophthalmol Vis Sci; 1985 Feb; 26(2):214-9. PubMed ID: 3972503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Terminal deoxynucleotidyl transferase deficiency reduces the incidence of autoimmune nephritis in (New Zealand Black x New Zealand White)F1 mice.
    Conde C; Weller S; Gilfillan S; Marcellin L; Martin T; Pasquali JL
    J Immunol; 1998 Dec; 161(12):7023-30. PubMed ID: 9862739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of the db (diabetes) gene in mice with hereditary load by generalized autoimmune pathology].
    Blokh KO; Poltorak VV
    Tsitol Genet; 1991; 25(5):40-5. PubMed ID: 1796510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental models in the search for new treatments of autoimmune renal diseases.
    Bach MA; Droz D
    Adv Nephrol Necker Hosp; 1980; 9():187-208. PubMed ID: 6773311
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative study of NZB mice under germfree and conventional conditions.
    Unni KK; Holley KE; McDuffie FC; Titus JL
    J Rheumatol; 1975 Mar; 2(1):36-44. PubMed ID: 1185733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of autoimmune diseases using animal disease models. 1) Molecular genetic analysis of autoimmune disease models].
    Nagasawa R; Maruyama N
    Nihon Rinsho; 1988 Apr; 46(4):845-9. PubMed ID: 3404706
    [No Abstract]   [Full Text] [Related]  

  • 20. [Immunity and virus].
    Kobayashi H; Kuzumaki N
    Nihon Rinsho; 1973 Dec; 31(12):3362-7. PubMed ID: 4598897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.